Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Data Analyst

Employer
Scilex Holding Company
Location
Palo Alto, CA
Start date
Apr 18, 2024

Job Details

Salary Range: $114,000 - $131,000 

The pay range for this position is expected to be between $114,000 - $131,000/annually; however, the base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills and experience.  The total compensation package for this position also includes medical benefits, 401(k) eligibility, vacation, sick time, and parental leave.  Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment.   

If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other payment or compensation program) at any time, including reasons related to individual performance, Company or individual department/team performance, and market factors.  

Scilex Holding Company’s pay range data is provided in accordance with local state pay transparency regulations.  Scilex Holding Company may post different minimum wage ranges for permanent residency petitions pursuant to US Department of Labor requirements.   

Scilex Holding Company is committed to equal employment opportunities, and a workplace that embraces diversity and inclusion for qualified individuals of all backgrounds.  

About Scilex

SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.  We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.

The company’s lead product ZTlido® (lidocaine topical system) 1.8%, is a marketed prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain. ZTlido® possesses novel delivery and adhesion technology designed to address many of the limitations of current prescription lidocaine patches by providing significantly improved adhesion and continuous pain relief throughout the 12-hour administration period.  Click here for ZTLido’s Important Safety Information and US Prescribing Information.

We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYBTM, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. We launched ELYXYBTM in the U.S. in April 2023 and are planning to commercialize GLOPERBA in 2024.

Our three product candidates are (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (“SEMDEXATM”), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica and has received Fast Track Status from the FDA. Currently there is no FDA approved non-opioid epidural injection to treat lumbosacral radicular pain, or sciatica; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a Phase 2, next-generation, triple-strength formulation of ZTlido, for the treatment of low back pain (“LBP”) and has received Fast Track Status from the FDA; and (iii) SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (“SP-104”), a novel low-dose delayed-release naltrexone hydrochloride being developed for the treatment of fibromyalgia.  If these product candidates are approved by the FDA, we believe each of them could become the treatment option for their respective indications in the United States.

SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them the most. Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.

If you’re a high-energy, compassionate, and collaborative individual with a strong desire to make a difference in patient’s lives, we encourage you to consider joining the Scilex Holding team!  

Role and Responsibilities

The Senior Data Analyst acts as the SME for commercial data, reporting and analytics workstreams for Scilex portfolio, including in-market, late stage, and early-stage pipeline products. This position will report to Associate Director, Sales Ops & Commercial Analytics within the Commercial Department. Will be primarily responsible for collection, curation of commercial data, creation, and delivery of standard reports & dashboards for executive and other home office decision makers and targeting/secondary data analytics.

Conducts thorough data analysis and develops data flows aligned to strategic vision. Understands and considers the business implications of data and communicates with impacted groups, as necessary. Implements appropriate processes for defining data requirements with external and internal partners. Coordinates internally & externally to define, document, and execute the setup, quality, cadence, and method of delivery of data files. These efforts will provide a fact-based way to measure and monitor business performance. As such, the Sr. Data Analyst will help set the foundation to identify and address business-critical questions along with other insights and outputs delivered by the larger Commercial team.

Key Responsibilities

  • Collaborate with Commercial team to help synthesize insights in a streamlined manner.
  • Architect complex data-centric and business intelligence solutions.
  •  Support advanced analytics efforts, such as HCP/account segmentation/targeting, subnational field effort analytics, marketing mix optimization, commercial ROI studies, and operational specialty pharmacy/specialty distributor channel analytics.
  • Develop first-hand knowledge of datasets and function as data expert to navigate emerging business needs and evolving data landscape.
  • Execute reporting suite for Commercial decision makers to enable “one view” of the market, ensuring single-source-of-truth reporting in collaboration with Commercial stakeholders. Master all Commercial data via governance and stewardship.
  • Continuously improve quality of data content, context, and associated business rules to ensure front-end usability of commercial data.
  • Consult with data custodians/IT to ensure safe custody, transport, and storage of commercial data and implementation of business rules.
  • Manage complexities of fragmented data sets from Scilex Holding’s distribution partners in context of specialty distribution model for applicable products.
  • Partner with IT and other functions to design and operate the customer master data management process, including business rule definitions and process flows to ensure data integrity and quality.
  • Identify and track key performance indicators, such as product market share, duration of therapy, patient compliance, etc., using select claims and electronic health record data sources.
  • Ensure that data flows and calculations are properly implemented on an ongoing basis.
  •  Ensure that the reporting suite is continuously relevant and meets emerging business needs by performing periodical audit.
  • Monitor automated data collection, analytics, and cleansing infrastructure.
  • Capture, develop, and document data definitions, business rules, and data quality requirements. Perform Quality Checks and implement controls for Sales and Marketing data.
  • Lead KPI definitions effort in partnership with various functional and operational leaders. Document and manage KPI definitions.

Qualifications and Education Requirements

  • Bachelor’s degree (business discipline preferred).
  • 5-7 years’ experience as a Data Analyst or in a similar role working directly with clinical healthcare data (e.g., medical claims, pharmacy claims, population-health data, EMR etc.)
  • Working knowledge of pharmaceutical industry data sources (e.g., IQVIA/ICON/Veeva Compass, BioMed Tracker, Analysource).
  • Prior experience developing business requirements documents and managing data projects.
  • Experience designing enterprise reporting solutions driven by a data lake, data warehouse or operational data store.
  • Strong analytical/critical thinking skills to address situations with operational complexity.
  • Coding skills and/or Analytical Tools experience (Alteryx/R/SAS/SQL/Tableau etc.) preferred.
  • Experience with using retail and specialty pharmacy data preferred.
  • Adept communication skills, including ability to summarize complex issues concisely and listen effectively to concerns and problems.
  • Cross-functional collaboration skills. Ability to work with people at various levels of the organization, including but not limited to, Marketing, Sales, Sales Operations, Managed Markets, Access Teams, Finance, IT, and other functions within and outside of Commercial.
  • Experience in implementation and/or management of CRM/SFA platforms, Sales Reports & Analytics, and business systems.
  • Good understanding of data security concepts.
  • Experience in coding ETL extraction tools.
  • Experience working with AWS databases, especially Redshift and EMR.
  • The role may require occasional travel (0-25%).

Preferred Skills

  • Experience with business intelligence tools / platforms is a plus.
  • Experience using Power Query, Power Pivot, Alteryx a plus.
  • Experience analyzing healthcare data a plus.
  • Understanding of medical coding system (CPT, ICD-10, DRG, etc.) a plus.
  • Experience managing data and/or analytics vendors preferred of business rules.
  • Manage complexities of fragmented data sets from Scilex Holding’s distribution partners in context of specialty distribution model for applicable products.
  • Partner with IT and other functions to design and operate the customer master data management process, including business rule definitions and process flows to ensure data integrity and quality.
  • Identify and track key performance indicators, such as product market share, duration of therapy, patient compliance, etc., using select claims and electronic health record data sources.
  • Ensure that data flows and calculations are properly implemented on an ongoing basis.
  • Ensure that the reporting suite is continuously relevant and meets emerging business needs by performing periodical audit.
  • Monitor automated data collection, analytics, and cleansing infrastructure.
  • Capture, develop, and document data definitions, business rules, and data quality requirements. Perform Quality Checks and implement controls for Sales and Marketing data.
  • Lead KPI definitions effort in partnership with various functional and operational leaders. Document and manage KPI definitions.

Company

SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), majority-owned by Sorrento, is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.

The company’s lead product ZTlido® (lidocaine topical system) 1.8%, is a branded prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain.

Scilex’s SP-102 (10 mg dexamethasone sodium phosphate viscous gel injection), or SEMDEXA™, for the treatment of Lumbar Radicular Pain has completed enrollment in a Phase III clinical trial and has received Fast Track Status from the FDA. If approved by the FDA, the company expects SP-102 to be the first FDA-approved non-opioid epidural injection to treat lumbosacral radicular pain, or sciatica, with the potential to replace 10 to 11 million off-label epidural steroid injections administered each year in the US.

SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them the most.

Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.

Company info
Website
Phone
(650) 516-4310
Location
960 San Antonio Road
Palo Alto
California
94303
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert